Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: LEIDOS BIOMEDICAL RESEARCH INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-07-03 to 2026-07-02
Current total value of award: $442590
Description: INSILICO AND EX-VIVO IMMUNOGENICITY ANALYSIS OF NCATS GENE THERAPY TEST